231 related articles for article (PubMed ID: 35098525)
1. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
Zeng F; You S; Dai X
Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
[TBL] [Abstract][Full Text] [Related]
2. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
Lu Y
Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
[TBL] [Abstract][Full Text] [Related]
3. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy.
Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L
Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689
[TBL] [Abstract][Full Text] [Related]
4. miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1.
Chen C; Tang J; Xu S; Zhang W; Jiang H
Biomed Res Int; 2020; 2020():2547902. PubMed ID: 32351986
[TBL] [Abstract][Full Text] [Related]
5. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
6. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
[TBL] [Abstract][Full Text] [Related]
7. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract][Full Text] [Related]
8. miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.
Chen S; Zhu X; Zheng J; Xu T; Xu Y; Chen F
Comput Math Methods Med; 2021; 2021():6241469. PubMed ID: 34306175
[TBL] [Abstract][Full Text] [Related]
9. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
10. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
Zhang D; Hua M; Zhang N
Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer.
Świtlik W; Wyżewski Z; Gregorczyk-Zboroch K; Gietler M; Pudlarz A; Szewińska J; Orzechowski S; Jakieła S; Szemraj J
Anticancer Res; 2024 Jun; 44(6):2445-2451. PubMed ID: 38821626
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
[TBL] [Abstract][Full Text] [Related]
13. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
Zhu J; Zeng Y; Li W; Qin H; Lei Z; Shen D; Gu D; Huang JA; Liu Z
Mol Cancer; 2017 Feb; 16(1):34. PubMed ID: 28158983
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
15. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract][Full Text] [Related]
16. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
[TBL] [Abstract][Full Text] [Related]
17. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior
of Lung Squamous Cell Carcinoma H520 Cells].
Gou L; He Y; Qiu P; Huang B
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
[TBL] [Abstract][Full Text] [Related]
19. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]